Thyroid cancer incidence and diagnostic radiography exposures, particularly computed tomography (CT) scanning and nuclear medicine examinations, have increased substantially in the USA. However, very few epidemiologic studies have directly investigated their associations. A population-based case-control study was conducted in Connecticut in 2010-2011, including 462 histologically confirmed incident thyroid cancer cases and 498 population-based controls. Multivariate unconditional logistic regression models were used to estimate the associations between diagnostic radiography and the risk of thyroid cancer, controlling for potential confounding factors. Exposure to any form of diagnostic radiography was associated with an increased risk of well-differentiated thyroid microcarcinoma [tumor size ≤ 10 mm, odds ratio (OR) = 2.76, 95% confidence interval (CI): 1.31-5.81]. The highest risk increase occurred with nuclear medicine examinations (excluding cardiology tests and thyroid uptake studies; OR = 5.47, 95% CI: 2.10-14.23), followed by chest CT scanning (OR = 4.30, 95% CI: 1.66-11.14), head and neck CT scanning (OR = 3.88, 95% CI: 1.75-8.63), upper gastrointestinal series (OR = 3.56, 95% CI: 1.54-8.21), lower gastrointestinal series (OR = 3.29, 95% CI: 1.41-7.66), kidney radiography involving dye injection into a vein or artery (OR = 3.21, 95% CI: 1.20-8.54), mammography (OR = 2.95, 95% CI: 1.14-7.61), chest radiography (OR = 2.93, 95% CI: 1.37-6.29), and abdomen CT scanning (OR = 2.54, 95% CI: 1.02-6.30). No significant associations were found between these imaging modalities and thyroid tumors larger than 10 mm. This study provides the first direct evidence that CT scanning and nuclear medicine examinations are associated with an increased risk of thyroid cancer. The novel finding that an array of diagnostic radiography procedures are associated with thyroid microcarcinomas warrants further investigation.
Introduction
Thyroid cancer has shown the fastest increase in incidence rate compared with all other cancers over the past decades, from 8.74/100 000 among women and 3.38/100 000 among men in 1994 to 21.82/100 000 among women and 7.37/100 000 among men in 2011 (Howlader et al., 2014) . It is now the fifth most common cancer among women in the USA (Howlader et al., 2014) . It has been suggested that the increasing incidence of thyroid cancer in the USA is predominantly due to the increased detection of subclinical disease, rather than due to an increase in the true occurrence of thyroid cancer, because the vast majority of cases have been small tumors and the mortality from the disease has remained stable (Davies and Welch, 2006) . Other investigators, however, have offered different opinions (Zhu et al., 2009; Enewold et al., 2011) . Recent studies have shown that approximately half of the variability in thyroid cancer incidence rates in the USA, at both the state and the county levels, cannot be explained by the 'overdiagnosis' theory, suggesting that environmental factors might also play a role (Morris et al., 2013; Udelsman and Zhang, 2014) .
The thyroid gland is among the most radiosensitive organs in the body. Exposure to ionizing radiation during childhood is the only established environmental risk factor for thyroid cancer (Sinnott et al., 2010) . Supportive evidence includes the dramatic outbreak of thyroid cancer, particularly among children and young adults, that occurred following atomic bomb detonations in Japan and nuclear accidents such as the Chernobyl event (Sinnott et al., 2010) . Ionizing radiation has been classified by the International Agency for Research on Cancer as a group 1 human carcinogen (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2012) . Exposure to diagnostic radiography has increased substantially in the USA, from an estimated mean per-capita dose of 0.54 mSv in 1980 to 3.0 mSv in 2006, and this trend is likely to continue (Mettler et al., 2008) . Computed tomography (CT) scanning and nuclear medicine examinations account for the majority of increased exposure (Mettler et al., 2008) . Both CT and nuclear medicine studies involve much larger doses of radiation compared with conventional radiographic procedures (Mettler et al., 2008) . However, very few epidemiologic studies have investigated the association between CT scanning and nuclear medicine examinations and the risk of thyroid cancer. The potential risk from CT scanning has been extrapolated using models from atomic bomb survivors, which estimate a thyroid cancer risk of 390 patients per million associated with neck CT scans (Mazonakis et al., 2007) . One recent study based on medical records showed a 40% increased risk of thyroid cancer associated with exposure to CT scanning during childhood and adolescence (Mathews et al., 2013) . However, this study did not collect information on exposure to CT scanning after 19 years of age. It is therefore unclear whether the results can be generalized to CT scanning performed during adulthood. In light of the parallel, increasing trends of thyroid cancer incidence and diagnostic radiography exposure, coupled with the paucity of epidemiologic studies directly investigating their association, we conducted a population-based case-control study in Connecticut to test the hypothesis that diagnostic radiography exposure is associated with an increased risk of thyroid cancer.
Materials and methods
Cases were histologically confirmed, incident thyroid cancer patients [papillary 8052, 8130, 8260, (8340) (8341) (8342) (8343) (8344) 8450, and 8452) , follicular (ICD-O-3: 8290, 8330-8332, and 8335), medullary (ICD-O-3: 8345, 8346, and 8510), or anaplastic (ICD-O-3: 8021)] from Connecticut diagnosed between 2010 and 2011. Eligible patients were aged between 21 and 84 years at diagnosis, had no previous diagnosis of cancer, with the exception of nonmelanoma skin cancer, and were alive at the time of interview. Cases were identified through the Yale Cancer Center's Rapid Case Ascertainment Shared Resource (RCA). The RCA acts as an agent of the Connecticut Tumor Registry. The Connecticut Public Health Code requires reporting of all cancer cases in licensed hospitals and clinical laboratories to the Connecticut Tumor Registry. RCA field staff are assigned geographically to survey all of the state's nonpediatric hospitals to identify newly diagnosed cases. Information on the cases identified in the field is sent regularly to the RCA data-entry staff, who enter, verify, and screen these data against the Connecticut Tumor Registry database. The Connecticut Tumor Registry has reciprocal reporting agreements with cancer registries in all adjacent states (and Florida) to identify residents from Connecticut with cancer diagnosed and/or treated in these states. A total of 701 eligible incident thyroid cancer cases were identified during the study period, with 462 (65.9%) completing in-person interviews. Population-based controls with Connecticut addresses were recruited using a random digit dialing method. A total of 498 individuals participated in the study, with a participation rate of 61.5%. Cases and controls were frequency-matched by age ( 5 years). Distributions of age, sex, and race were similar between the participants and nonparticipants for both cases and controls.
All procedures were performed in accordance with a protocol approved by the Human Investigations Committee at Yale and the Connecticut Department of Public Health. After approval by the hospitals and by each participant's physician (cancer cases), or after selection through random sampling (control population), potential participants were approached by letter and then over the phone. Those who agreed were interviewed by trained study interviewers, either at their homes or at a convenient location. After obtaining written consent, a standardized, structured questionnaire was used to obtain information on diagnostic radiography exposures and other major known or suspected risk factors that might have confounded the association between diagnostic radiography exposure and risk of thyroid cancer.
With regard to diagnostic radiography exposure, the participants were asked about the following diagnostic radiography procedures: (a) upper gastrointestinal series, (b) lower gastrointestinal series, (c) chest radiography, (d) head and neck CT scanning, (e) chest CT scanning, (f) abdominal CT scanning, (g) pelvic CT scanning, (h) nuclear cardiology tests, (i) thyroid uptake studies using I-131 or another radioactive agent, (j) nuclear medicine tests including bone, brain, and liver scans, or other studies that involve pre-test injection of a radioactive agent, (k) kidney radiography involving dye injection into a vein or artery, and (l) mammography. The participants were asked whether they had ever undergone any of the procedures. If a participant answered 'yes', he/she was asked how old he/she was during the initial procedure, as well as the total number of procedures he/she had undergone. 'Exposure' to diagnostic radiography was defined as ever exposure of patients to radiography, where 'nonexposure' was defined as no exposure of the participant to any of these 12 procedures. For dental radiography, participants were asked how often they had undergone dental radiography, and how many of these were full mouth series and Panorex exams.
Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using unconditional logistic regression models to estimate the associations between diagnostic radiography exposures and the risk of thyroid cancer by histologic subtype and tumor size, and to control for potential confounders. Potentially confounding variables included in the final model were age, sex, education level, family history of thyroid cancer, previous benign thyroid disease, BMI, alcohol consumption, and radiation treatment. Adjustment for other variables, such as family income, smoking, race, and occupational radiation exposure, did not result in material changes in the observed associations, and thus they were not included in the final model. Decisions on the covariates to be included in the final model were based on a greater than 10% change in the risk estimates. Because of the possibility that diagnostic radiography was performed as part of the diagnostic workup for thyroid cancer, we excluded participants who had their first diagnostic radiography 5 years or less before their diagnosis (for cases) or interview (for controls). All tests of statistical significance were two-sided. All analyses were carried out using SAS (version 9.3; SAS Institute Inc., Cary, North Carolina, USA).
Results
Of the 462 patients with thyroid cancer, the majority were diagnosed with papillary thyroid cancer (392, 84.8%), followed by follicular (56, 12.1%), medullary (12, 2.6%), anaplastic (1, 0.2%), and others (one, 0.2%). A total of 217 (47.0%) cases were microcarcinomas (≤ 10 mm), and among them, 190 were papillary and 24 were follicular. The mean age at diagnosis of thyroid cancer was 51 years. The patients were more likely to be women, of lower education, obese, and nondrinkers compared with controls (Table 1) . They were also more likely to have had a family history of thyroid cancer and a previous diagnosis of benign thyroid disease, as well as to have undergone previous radiation treatment. Distributions of family income, race, and smoking between cases and controls were similar.
Exposure to any diagnostic radiography technique was associated with a borderline significant increased risk of thyroid cancer (OR = 1.63, 95% CI: 0.98-2.72, Table 2 ). Several specific procedures were associated with an increased risk of thyroid cancer: upper gastrointestinal series (OR = 1.82, 95% CI: 1.01-3.29), chest radiography (OR = 1.79, 95% CI: 1.06-3.02), head and neck CT scanning (OR = 2.13, 95% CI: 1.21-3.74), chest CT scanning (OR = 2.63, 95% CI: 1.30-5.29), abdominal CT scanning (OR = 1.97, 95% CI: 1.04-3.75), and nuclear medicine examinations (OR = 2.86, 95% CI: 1.39-5.89). Several others were not significantly associated with the risk of thyroid cancer, including lower gastrointestinal series (OR = 1.77, 95% CI: 0.98-3.19), pelvic CT scanning (OR = 1.12, 95% CI: 0.52-2.39), nuclear cardiology tests (OR = 1.48, 95% CI: 0.75-2.90), kidney radiography involving dye injection into a vein or artery (OR = 1.53, 95% CI: 0.74-3.17), and mammography (OR = 1.43, 95% CI: 0.71-2.85). When we analyzed data by histologic subtype, similar associations were observed for welldifferentiated (including papillary and follicular) thyroid cancer. Slightly weakened associations were found for papillary thyroid cancer. We did not analyze the data for follicular thyroid cancer alone and other subtypes because of small numbers.
We conducted stratified analyses by tumor size for welldifferentiated thyroid cancer (Table 3 ). Exposure to any diagnostic radiography technique was associated with an increased risk of microcarcinoma (tumor size ≤ 10 mm, OR = 2.76, 95% CI: 1.31-5.81). The highest risk was associated with nuclear medicine examinations (OR = 5.47, 95% CI: 2.10-14.23), followed by chest CT scanning (OR = 4.30, 95% CI: 1.66-11.14), head and neck CT scanning (OR = 3.88, 95% CI: 1.75-8.63), upper gastrointestinal series (OR = 3.56, 95% CI: 1.54-8.21), lower gastrointestinal series (OR = 3.29, 95% CI: 1.41-7.66), kidney radiography involving dye injection into a vein or artery (OR = 3.21, 95% CI: 1.20-8.54), mammography (OR = 2.95, 95% CI: 1.14-7.61), chest radiography (OR = 2.93, 95% CI: 1.37-6.29), and abdominal CT scanning (OR = 2.54, 95% CI: 1.02-6.30). No significant associations were observed between well-differentiated thyroid cancer and tumor size greater than 10 mm. Similar associations with tumor size were observed for papillary thyroid cancer (data not shown).
For well-differentiated thyroid microcarcinomas, several diagnostic radiography procedures showed an increased risk with an increasing number of procedures (Table 4) . A significant dose-response was observed for ever exposure to any diagnostic radiography procedure (P for trend = 0.045), chest radiography (P for trend = 0.0075), head and neck CT scanning (P for trend = 0.015), chest CT scanning (P for trend = 0.018), abdomen CT scanning (P for trend = 0.026), kidney radiography (P for trend = 0.0066), and mammography (P for trend = 0.037). No clear patterns were observed among patients for whom 6-10 years or more than 10 years had elapsed since their first procedure (Table 4 ). Similar patterns were observed for papillary thyroid microcarcinomas (data not shown).
Fewer than 10% of the study participants reported receiving their first diagnostic radiography procedure at the age of 15 years or younger. Analysis of the association for exposure/nonexposure to diagnostic radiography demonstrated a higher increased risk for welldifferentiated microcarcinoma among those who had their first diagnostic radiography procedure at the age 15 years or younger (OR = 4.07, 95% CI: 1.63-10.20) compared with those older than 15 years (OR = 2.34, 95% CI: 1.10-4.98).
Compared with individuals who underwent dental radiography less than once every 5 years, those who underwent dental radiography more than once a year had a borderline significantly increased risk for thyroid cancer (OR = 2.20, 95% CI: 1.03-3.72; Table 5 ). The increased risk associated with a higher frequency of dental radiography exposure was weakened for well-differentiated (OR = 2.07, 95% CI: 0.95-4.50) and papillary thyroid cancer (OR = 1.81, 95% CI: 0.81-4.04). No significant associations were observed for full mouth series and Panorex exams (data not shown). No significant associations were observed for different tumor sizes (data not shown).
Discussion
This study suggests a strong positive association between diagnostic radiography exposure and the risk of thyroid cancer. It is critical to note that this increased risk was specific to microcarcinomas. Thyroid microcarcinoma has shown the fastest increase in incidence, resulting in an apparent epidemic of thyroid cancer (Howlader et al., 2014) . In the current study, approximately half of all newly diagnosed thyroid cancers were microcarcinomas, (yes, no) , radiation treatment (yes, no), and dental radiography exposure (less than once every 5 years, once every 2-5 years, once a year, more than once a year). b Excluded nuclear cardiology tests and thyroid uptake study. c Procedures involving injection of a dye into a vein or artery. d Limited to women only. and the vast majority of these were micropapillary cancers, which is consistent with the data from Surveillance Epidemiology End Results (Howlader et al., 2014) . It is unclear why diagnostic radiography exposures are only associated with microcarcinomas. It is possible that individuals who have had diagnostic radiography exposures are more likely to undergo medical screening and, therefore, their thyroid cancers are more likely to be diagnosed before a microcarcinoma progresses. However, the finding that the associations remained similar for a lag period of 6-10 years, or more than 10 or 20 years, after the first exposure to diagnostic radiography suggests that thyroid cancer is a very slow-growing tumor. Because of the increased detection of small thyroid nodules, newly developed disease caused by increased diagnostic radiography exposure is likely being identified earlier. It is also possible that diagnostic radiation-associated thyroid microcarcinomas constitute a new disease with a different etiologic profile. An observational study of papillary microcarcinoma from Japan found that the proportions of patients whose papillary microcarcinomas showed enlargement by 3 mm or more were 6.4 and 15.9% at 5 and 10 years of follow-up, respectively, and tumor enlargement was not related to patient background or clinical features (Ito et al., 2010) .
A recent report has suggested that the increased incidence of thyroid cancer is unlikely to be due to environmental factors or therapeutic radiation because the percentage of RET/PTC rearrangements has decreased, on the basis of a single-institute study (Jung et al., 2014) . However, the higher prevalence of RET/PTC rearrangements in radiation-induced thyroid cancer was mainly identified in post-Chernobyl tumors, which resulted from exposure to an extremely high dose of radiation (Nikiforova et al., 2004) . No clear evidence has shown that exposure to low-dose radiation through medical practice induces RET/PTC rearrangements.
Several earlier epidemiological studies have investigated the association between exposure to diagnostic radiography and thyroid cancer risk, but they have provided inconsistent results (Preston-Martin et al., 1987; Ron et al., 1987; Franceschi et al., 1989; Hallquist et al., 1994; Inskip et al., 1995; Wingren et al., 1997; Hallquist and Nasman, 2001; Neta et al., 2013) . However, none of these studies examined the effect of CT scanning and nuclear medicine examinations, as all these studies collected information on diagnostic radiography through the 1980s, when CT scanning and nuclear medicine examinations were less common. The current study provides the first direct evidence that exposure to CT scanning and nuclear medicine examinations during adulthood is associated with an increased risk of thyroid cancer, and it confirms the prior finding that exposure to CT scanning during childhood is associated with an increased risk of thyroid cancer (Mathews et al., 2013) . Nuclear medicine examinations deliver radiation doses comparable to those associated with CT scanning. The strongest association was observed for thyroid uptake studies, which could be due to the underlying disease. Nuclear cardiology tests were not found to be significantly associated with thyroid cancer risk in this study. Other nuclear medicine tests included bone, brain, and liver scanning, or other studies that involve pre-test injection of a radioactive agent. These tests showed a significant association with thyroid cancer. The current study did not collect information on the specific organs examined by these tests; however, it is possible that the increased risk was driven by thyroid gland exposure.
This study also showed an increased risk for thyroid cancer to be associated with a high frequency of dental radiography exposure. Earlier studies involving dental radiography have yielded inconsistent results (Preston-Martin et al., 1987; Ron et al., 1987; Hallquist and Nasman, 2001; Memon et al., 2010; Neta et al., 2013) . Studies showed that an increased thyroid cancer risk was mainly seen among those who had undergone dental radiography before the 1970s (Hallquist and Nasman, 2001; Memon et al., 2010; Neta et al., 2013) .
Potential limitations should be considered when interpreting the findings of this study. Information on diagnostic radiography exposures was based on self-reporting. Therefore, potential recall bias cannot be ruled out.
Although medical records are generally considered an ideal tool for obtaining information on diagnostic radiography exposure, data from medical records may underestimate exposure because of incomplete records (Inskip et al., 1995; Berrington de Gonzalez et al., 2003) . Validation studies from the USA comparing medical records and interviews with regard to histories of diagnostic radiography have suggested nondifferential reporting error between thyroid cancer cases and controls (Preston-Martin et al., 1985; Berrington de Gonzalez et al., 2003) . As a validation study from Sweden found that differential recall bias between thyroid cancer cases and controls was found among those who were younger than 50 years (Hallquist and Jansson, 2005) , we conducted a stratified analysis by age and did not observe significant differences in the associations between the age groups less than 50 years and at least 50 years. In addition, our positive findings were limited only to thyroid microcarcinomas, supporting the notion that differential recall bias is less likely to play a major role. We did not collect information on age at the time of each diagnostic radiography procedure, which limited our ability to distinguish how many procedures were administered during childhood and adolescence. We can only evaluate the association with the age of the first diagnostic radiography exposure. As all diagnostic radiography procedures were based on self-reporting, information on radiation doses to the thyroid gland for each procedure was not available. Estimated doses to the thyroid gland for some of the diagnostic radiography procedures have been published. However, many of these publications have limited information on specific procedures such as CT scanning of the abdomen and nuclear medicine tests. Therefore, we were unable to examine the relationship based on cumulative radiation doses from diagnostic radiography exposures. Information on reasons for each diagnostic radiography procedure was not available for the study, which limited our ability to examine the associations by underlying reasons. Finally, our sample size was limited for the purpose of examining rarer histologic subtypes such as follicular, medullary, and anaplastic thyroid cancers.
The possibility of reverse causation could be a potential concern, as symptoms of a precancerous condition or early symptoms of the cancer itself might prompt a diagnostic radiography procedure. However, this phenomenon is unlikely to be the sole explanation in this study, given the following observations. First, because of the possibility that diagnostic radiography was performed as a part of the diagnostic workup for thyroid cancer, we excluded participants who had their first diagnostic radiography 5 years or less before their diagnosis (for cases) or interview (for controls). Although the associations were attenuated after excluding those who were diagnosed within 5 years of their first diagnostic radiography, they remained statistically significant. The associations were sustained in the '6-10 year' and 'more than 10 year' ranges after the first diagnostic radiography exposure. Second, the associations increased with increasing frequency of diagnostic radiography procedures, and many of them showed a significant dose-response relationship. Third, larger associations were found for diagnostic radiography being administered for the first time during childhood, as seen in the Life Span Study of survivors of the Japanese atomic bombings (Sinnott et al., 2010) . Finally, the associations were stronger when the site of CT scanning was anatomically closer to the thyroid gland.
Conclusion
This study provides new and direct evidence showing strong associations between an array of diagnostic radiography procedures and the risk of thyroid cancer. The observed associations were mainly seen for thyroid microcarcinomas. Although we cannot rule out the possibility that increased diagnostic radiography procedures might have prompted the earlier diagnosis of thyroid cancer, physicians should cautiously weigh the diagnostic value of CT scanning and nuclear medicine examinations against the potential risks. The estimated populationattributable risk was 59% (95% CI: 37-85%), suggesting that 37-85% of well-differentiated thyroid microcarcinomas in the US population could be explained by exposure to diagnostic radiography. Future prospective studies are warranted to investigate the association between CT scanning and nuclear medicine tests and the risk of thyroid cancer. It is also essential to identify populations that are especially susceptible to the effects of diagnostic radiography.
